VF
SLXN

Virtu Financial’s Silexion Therapeutics Corp Ordinary Shares SLXN Stock Holding History

Virtu Financial’s Portfolio SLXN Stock Details SLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$12K Buy
+951
New +$12K ﹤0.01% 1310
2024
Q4 		– Sell
-197
Closed -$14K – 2190
2024
Q3 		$14K Buy
+197
New +$14K ﹤0.01% 1167